HilleVax, Inc., (HLVX): Price and Financial Metrics
HLVX Price/Volume Stats
| Current price | $11.89 | 52-week high | $20.22 |
| Prev. close | $11.86 | 52-week low | $9.94 |
| Day low | $11.79 | Volume | 97,067 |
| Day high | $12.50 | Avg. volume | 135,405 |
| 50-day MA | $15.99 | Dividend yield | N/A |
| 200-day MA | $14.39 | Market Cap | 591.18M |
HLVX Stock Price Chart Interactive Chart >
HilleVax, Inc., (HLVX) Company Bio
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Latest HLVX News From Around the Web
Below are the latest news stories about HILLEVAX INC that investors may wish to consider to help them evaluate HLVX as an investment opportunity.
Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 10,000 Shares of HilleVax Inc ...In a notable insider transaction, Chief Medical Officer Astrid Borkowski sold 10,000 shares of HilleVax Inc (NASDAQ:HLVX) on December 15, 2023. |
Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 20,000 Shares of HilleVax Inc ...In a notable insider transaction, Chief Medical Officer Astrid Borkowski sold 20,000 shares of HilleVax Inc (NASDAQ:HLVX) on December 4, 2023. |
Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to TradeThe mean of analysts' price targets for HilleVax, Inc. (HLVX) points to a 92.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the UpgradeHilleVax, Inc. (HLVX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
Does HilleVax, Inc. (HLVX) Have the Potential to Rally 107.23% as Wall Street Analysts Expect?The mean of analysts' price targets for HilleVax, Inc. (HLVX) points to a 107.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
HLVX Price Returns
| 1-mo | -26.19% |
| 3-mo | -19.82% |
| 6-mo | 14.88% |
| 1-year | -14.28% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -25.92% |
| 2023 | -4.06% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...